Oxycodone Sandoz

Active Ingredient:: Oxycodone Hydrochloride
Origin:: EU

Oxycodone Sandoz (Oxycodone Hydrochloride)

International sale not permitted. Listed for the domestic market and B2B only.

Oxycodone Hydrochloride, the active ingredient in Oxycodone Sandoz, is an opioid analgesic presented as a solid oral dosage form for oral use. It is prescribed for the management of moderate to severe pain in adult patients. GNH India supplies Oxycodone Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH India supplies Oxycodone Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Sandoz

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oxycodone Sandoz is an opioid analgesic that acts on the central nervous system to relieve pain.

Acute pain: Provides rapid relief of severe pain following surgery or injury.
Chronic cancer pain: Helps control persistent pain associated with malignant disease.
Severe non‑cancer chronic pain: Alleviates long‑term pain when other treatments are insufficient.

How It Works

Oxycodone binds to μ‑opioid receptors in the brain and spinal cord, activating inhibitory G‑protein pathways that reduce neuronal excitability and diminish the perception of pain. This receptor activation also modulates neurotransmitter release, contributing to its analgesic effect.

Side Effects

Adverse reactions to oxycodone may vary in frequency and severity.

Common Side Effects

Nausea: Mild to moderate upset stomach.
Constipation: Reduced bowel motility leading to hard stools.
Drowsiness: Generalized sedation or feeling of fatigue.
Dizziness: Light‑headed sensation, especially when standing quickly.
Dry mouth: Reduced salivation causing a parched feeling.
Sweating: Increased perspiration without exertion.

Serious or Rare Side Effects

Respiratory depression: Slowed breathing that can be life‑threatening.
Severe hypotension: Marked drop in blood pressure causing faintness.
Seizures: Uncontrolled electrical activity in the brain.
Allergic reactions: Rash, itching, swelling, or anaphylaxis.
Dependence and withdrawal: Physical and psychological reliance with withdrawal symptoms on abrupt cessation.
Opioid‑induced constipation (OIC) that does not respond to standard laxatives.

Precautions & Warnings

When prescribing Oxycodone Sandoz, clinicians should consider several safety measures.

Assess pain severity: Confirm that pain is moderate to severe before initiating therapy.
Evaluate opioid tolerance: Determine if the patient has prior exposure to opioids.
Monitor for respiratory depression: Observe breathing rate, especially after dose initiation or increase.
Avoid concurrent CNS depressants: Limit use of alcohol, benzodiazepines, or other sedatives.
Educate on dependence risk: Inform patients about the potential for addiction and proper disposal.
Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Avoid Interactions

Oxycodone Sandoz can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): May increase oxy‑acetyl levels and risk of overdose.
CNS depressants (e.g., benzodiazepines, barbiturates, alcohol): Heightened sedation and respiratory depression.
MAO inhibitors: Can cause severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

CYP2D6 inhibitors (e.g., fluoxetine): May reduce conversion to active metabolites.
Diuretics: May exacerbate hypotension.
Anticholinergic agents: May worsen constipation.

Frequently Asked Questions

Oxycodone Sandoz is a generic immediate‑release formulation of oxy‑hydrochloride that is prescribed to manage moderate to severe pain, including acute postoperative pain, cancer‑related pain, and chronic non‑cancer pain when other analgesics are insufficient.

Oxycodone binds to μ‑opioid receptors in the central nervous system, activating inhibitory pathways that lower neuronal firing and reduce the transmission of pain signals, thereby decreasing the perception of pain.

The appropriate dose of Oxycodone Sandoz is determined by the prescribing clinician based on the patient’s pain intensity, prior opioid exposure, and overall health status. Dosage adjustments are made to achieve effective pain control while minimizing side effects.

Oxycodone is classified as a pregnancy‑category C medication and is generally not recommended during pregnancy or while breastfeeding because it may cause fetal harm or neonatal withdrawal. Use only if the potential benefit justifies the potential risk.

To place an order, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Oxycodone provides strong μ‑opioid receptor agonism similar to morphine but often has a faster onset of action. Compared with weaker opioids such as codeine, it offers more potent analgesia, making it suitable for severe pain, though it also carries a higher risk of dependence and respiratory depression.

Store Oxycodone Sandoz at ambient temperature, preferably below 25 °C, in its original container to protect it from moisture and light. Do not expose the product to excessive heat or humidity.

Oxycodone Sandoz is administered orally, typically as a tablet that is swallowed whole with water. It should be taken exactly as prescribed, without crushing or chewing, unless a specific formulation permits such modification.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 10 Oct 2026

Disclaimer

International sale not permitted. Listed for the domestic market and B2B only.

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.